BFLY ▲ +5.6% - Butterfly Network, Inc.
$BFLY Needham analyst David Saxon initiated coverage of Butterfly Network with a Buy rating and $10 price target. The company's "differentiated" semiconductor chip base ultrasound system is enabling the development of a new wave of medical technologies that spans many categories, the analyst tells investors in a research note. The firm believes Butterfly can participate in new markets, some of which represent significant opportunities, while its core ultrasound platform represents "multiple sources of near-term upside."
Butterfly Network rose 5.6% after Needham analyst David Saxon initiated coverage with a Buy rating and $10 price target, citing the company's differentiated semiconductor-based ultrasound system and potential to enter new markets while driving near-term growth from its core platform. The positive initiation and price target provided fresh analyst validation for the healthcare technology company's competitive positioning.
22-SEP-2026 09:07 AM ET
Share this post
More filings for $BFLY
BFLY ▲ +1.4% - Butterfly Network, Inc.Nov 17, 2026BFLY - Butterfly Network, Inc. - SEC Filing Update (05-NOV-2026) | ThinkSabio - Stocks SimplifiedNov 5, 2026BFLY ▲ +8.7% - Butterfly Network, Inc.Oct 29, 2026BFLY ▲ +2.1% - Butterfly Network, Inc.Oct 27, 2026BFLY ▼ -0.2% - Butterfly Network, Inc.Oct 13, 2026BFLY ▼ -1.2% - Butterfly Network, Inc.Oct 8, 2026
View full $BFLY filing history →💬 Comments
Loading comments…
Leave a comment
